ProKidney Corp. (PROK)
NASDAQ: PROK
· Real-Time Price · USD
2.54
0.18 (7.63%)
At close: Aug 18, 2025, 3:59 PM
2.54
0.00%
Pre-market: Aug 19, 2025, 04:18 AM EDT
7.63% (1D)
| Bid | 2.49 |
| Market Cap | 759.45M |
| Revenue (ttm) | 306K |
| Net Income (ttm) | -68.43M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -4.54 |
| Forward PE | -4.24 |
| Analyst | Strong Buy |
| Ask | 2.57 |
| Volume | 2,611,157 |
| Avg. Volume (20D) | 13,438,258 |
| Open | 2.35 |
| Previous Close | 2.36 |
| Day's Range | 2.35 - 2.59 |
| 52-Week Range | 0.46 - 7.13 |
| Beta | 1.81 |
About PROK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PROK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PROK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-8.67%
PROK stock has given up its prior gain. ProKidney ...
Unlock content with
Pro Subscription
1 month ago
-8.67%
ProKidney shares are trading higher after the company announced it is aligned with the FDA regarding the accelerated approval and pathway for Rilparencel.
1 month ago · https://247wallst.com
Live Nasdaq Composite: Markets Attempt Gains on Renewed Trade Deal BetsLive Updates Live Coverage Has Ended X Executive Shakeup 1:06 pm by Gerelyn Terzo Uncertainty has gripped yet another one of Elon Musk’s companies after X CEO Linda Yaccarino revealed she would ...
